Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MERCK & CO., INC.

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Merck & Co., Inc.
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:

- sale of pharmaceutical products (73.2%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;

- sale of vaccines (16.4%);

- sale of animal health products (9.8%);

- other (0.6%).

Net sales are distributed geographically as follows: the United States (43.8%), Europe/Middle East/Africa (28.3%), China (7.6%), Japan (7%), Asia/Pacific (6%), Latin America (4.7%) and other (2.6%).

Number of employees : 74 000 people.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Pharmaceutical41,75189.6%43,02189.6% +3.04%
Animal Health4,3939.4%4,7039.8% +7.06%
Other521.001.1%247.000.5% -52.59%
Other Segment175.000.4%23.000% -86.86%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
United States20,32543.6%21,02743.8% +3.45%
Europe, Middle East and Africa12,70727.3%13,60028.3% +7.03%
China3,2076.9%3,6247.5% +13%
Japan3,5837.7%3,3767% -5.78%
Asia Pacific2,9436.3%2,8646% -2.68%
Latin America2,4695.3%2,2744.7% -7.9%
Other1,6063.4%1,2292.6% -23.47%
Managers
NameAgeSinceTitle
Kenneth Frazier652021Chairman & Chief Executive Officer
Robert Davis542021President
Caroline Litchfield-2021Chief Financial Officer & Executive Vice President
Sandy Tremps-2016Vice President-R&D IT CIO
Dave Williams--Chief Information & Digital Officer
Thomas Henry Glocer602007Independent Director
Leslie Brun672014Lead Independent Director
Patricia Russo671995Independent Director
Peter C. Wendell692003Independent Director
Pamela J. Craig632015Independent Director
Members of the board
NameAgeSinceTitle
Kenneth Frazier652021Chairman & Chief Executive Officer
Thomas Henry Glocer602007Independent Director
Leslie Brun672014Lead Independent Director
Patricia Russo671995Independent Director
Peter C. Wendell692003Independent Director
Pamela J. Craig632015Independent Director
Paul B. Rothman, Dr.622015Independent Director
Inge Thulin662018Independent Director
Mary Ellen Coe522019Independent Director
Kathy Warden482020Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,577,858,139 2,530,302,446 70.7% 1,045,799,775 29.2% 70.7%
Shareholders
NameEquities%
The Vanguard Group, Inc. 213,886,123 8.45%
Capital Research & Management Co. 138,704,087 5.48%
SSgA Funds Management, Inc. 112,688,934 4.45%
BlackRock Fund Advisors 59,641,925 2.36%
Geode Capital Management LLC 42,774,518 1.69%
Wellington Management Co. LLP 39,596,585 1.56%
Capital Research & Management Co. (International Investors) 33,179,434 1.31%
Northern Trust Investments, Inc.(Investment Management) 32,086,293 1.27%
Norges Bank Investment Management 27,515,487 1.09%
Massachusetts Financial Services Co. 24,733,151 0.98%
Holdings
NameEquities%Valuation
NGM Biopharmaceuticals, Inc. (NGM) 12,955,01616.8%195,102,541 USD
Sutro Biopharma, Inc. (STRO) 2,723,5095.91%50,684,502 USD
KalVista Pharmaceuticals, Inc. (KALV) 1,070,5894.38%28,905,903 USD
Lava Therapeutics B.V. (LVTX) 1,082,6794.27%12,288,407 USD
4D pharma plc (DDDD) 8,315,0234.61%11,577,256 USD
Yumanity Therapeutics, Inc. (YMTX) 526,9995.17%8,105,245 USD
Markets and indexes
-
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Company contact information
Merck & Co., Inc.
2000 Road Galloping Hill
PO Box 100
NJ 07033 Kenilworth, New Jersey


Phone : +1 908 423 1000
Fax : +1 908 735 1253
web site : http://www.merck.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Merck & Co., Inc.
Sector Other Pharmaceuticals
1st jan.Capitalization (M$)
MERCK & CO., INC.-6.34%191 677
JOHNSON & JOHNSON4.52%433 167
ROCHE HOLDING AG11.21%330 710
PFIZER, INC.7.55%221 613
NOVARTIS AG0.77%210 689
ABBVIE INC.8.10%204 582
ELI LILLY AND COMPANY32.39%203 185
NOVO NORDISK A/S21.76%194 583
ASTRAZENECA PLC13.91%154 316
BRISTOL-MYERS SQUIBB COMPANY8.69%150 538
AMGEN INC.4.32%137 807
SANOFI12.91%134 782
GLAXOSMITHKLINE PLC5.59%99 903
JIANGSU HENGRUI MEDICINE CO., LTD.-23.76%71 480
CHUGAI PHARMACEUTICAL CO., LTD.-17.95%68 012
BAYER AG11.33%63 871
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.15%54 016
DAIICHI SANKYO COMPANY, LIMITED-26.42%45 597
ASTELLAS PHARMA INC.22.43%32 805
EISAI CO., LTD.52.54%29 701